EUVIMEDEUVIMED entdecken
Crossref

Unraveling the obesity paradox in hepatocellular carcinoma: relative role of elevated body mass index on detrimental effects of postoperative complications

Miho Akabane, Jun Kawashima, Abdullah Altaf, Selamawit Woldesenbet, François Cauchy, Federico Aucejo, Irinel Popescu, Minoru Kitago, Guillaume Martel, Francesca Ratti, Luca Aldrighetti, George A Poultsides und 12 weitere

HPB · 2025

DOI: 10.1016/j.hpb.2025.05.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift HPB, 2025. Verfasst von Miho Akabane und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, The Ohio State University, Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Body Mass Index, Hepatectomy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The "obesity paradox" suggests higher body mass index (BMI) may correlate with better long-term outcomes in cancers. The impact of BMI on hepatocellular carcinoma (HCC) resection, regarding postoperative complications, remains unclear. We examined the interplay between BMI and complications on recurrence-free survival (RFS) among patients undergoing HCC resection. METHODS: Patients undergoing hepatectomy for HCC (2000-2023) were identified from an international database. Kaplan-Meier and Cox analyses assessed the protective impact of high BMI on RFS, considering interactions with complications. RESULTS: Among 1,588 patients (median BMI: 25.2 kg/m²; BMI > 25.0:793, BMI ≤ 25.0:795), 560 (35.3%) experienced complications. BMI > 25.0kg/m² was linked to better 5-year RFS than BMI ≤ 25.0kg/m² (50.3% vs 45.4%; p = 0.006). Patients without complications had better 5-year RFS than those with complications (51.7% vs 40.7%; p 25.0kg/m² was associated with better RFS (45.6% vs 34.2%; p 25.0 kg/m² had RFS comparable to patients without complications, regardless of BMI. Multivariable analysis identified complications (HR:1.31 [1.08-1.60]; p = 0.007) as a predictor of worse RFS, while BMI > 25.0 kg/m² (HR: 0.79 [0.68-0.96]; p = 0.020) was protective. Spline analysis demonstrated recurrence risk declined with increasing BMI among patients with complications, crossing below 1 around 25.0kg/m². Stratifying the complication cohort (BMI ≤ 25.0/25.0-30.0/>30.0 kg/m²) demonstrated dose-dependent RFS improvement (p = 0.005). CONCLUSION: High BMI correlated with better RFS following HCC resection among patients with complications. Concerns about complications should not deter surgery among high-BMI patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsBody Mass IndexHepatectomyObesityPostoperative ComplicationsHumansMaleFemaleMiddle AgedRisk FactorsAgedTime FactorsTreatment OutcomeDatabases, FactualRetrospective StudiesRisk AssessmentDisease-Free SurvivalKaplan-Meier EstimateProportional Hazards ModelsObesity Paradox

Autor:innen und Institutionen

  • Department of Surgery, The Ohio State University, Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.
  • Department of Hepatobiliopancreatic Surgery, APHP, Beaujon Hospital, Clichy, France.
  • Department of General Surgery, Cleveland Clinic Foundation, OH, USA.
  • Department of Surgery, Fundeni Clinical Institute, Bucharest, Romania.
  • Department of Surgery, Keio University, Tokyo, Japan.
  • Department of Surgery, University of Ottawa, Ottawa, Ontario, Canada.

Zitieren

APA

Akabane, M., Kawashima, J., Altaf, A., Woldesenbet, S., Cauchy, F., Aucejo, F., Popescu, I., Kitago, M., Martel, G., Ratti, F., Aldrighetti, L., Poultsides, G. A., Imaoka, Y., Ruzzenente, A., Endo, I., Gleisner, A., Marques, H. P., Oliveira, S., Balaia, J., …, & Pawlik, T. M. (2025). Unraveling the obesity paradox in hepatocellular carcinoma: relative role of elevated body mass index on detrimental effects of postoperative complications. HPB. https://doi.org/10.1016/j.hpb.2025.05.005

Vancouver

Akabane M, Kawashima J, Altaf A, Woldesenbet S, Cauchy F, Aucejo F, et al. Unraveling the obesity paradox in hepatocellular carcinoma: relative role of elevated body mass index on detrimental effects of postoperative complications. HPB. 2025. doi:10.1016/j.hpb.2025.05.005

BibTeX
@article{Akabane2025,
  author = {Akabane, Miho and Kawashima, Jun and Altaf, Abdullah and Woldesenbet, Selamawit and Cauchy, François and Aucejo, Federico and Popescu, Irinel and Kitago, Minoru and Martel, Guillaume and Ratti, Francesca and Aldrighetti, Luca and Poultsides, George A and Imaoka, Yuki and Ruzzenente, Andrea and Endo, Itaru and Gleisner, Ana and Marques, Hugo P and Oliveira, Sara and Balaia, Jorge and Lam, Vincent and Hugh, Tom and Bhimani, Nazim and Shen, Feng and Pawlik, Timothy M},
  title = {Unraveling the obesity paradox in hepatocellular carcinoma: relative role of elevated body mass index on detrimental effects of postoperative complications},
  journal = {HPB},
  year = {2025},
  doi = {10.1016/j.hpb.2025.05.005}
}
Kostenlos starten →